Latest news and insights on the pharmaceutical industry | Indian Pharma Post

Results For "Anuh-Pharma"

4 News Found

Briefs: Godavari Biorefineries and Anuh Pharma
News | July 16, 2025

Briefs: Godavari Biorefineries and Anuh Pharma

Godavari Biorefineries receives patent from CNIPA

Briefs: Krsnaa Diagnostics and Anuh Pharma
News | September 27, 2024

Briefs: Krsnaa Diagnostics and Anuh Pharma

Krsnaa Diagnostics receives LoI from RINPAS for radiology services

Anuh Pharma posts Q4 FY23 PAT at Rs. 9.62 Cr
News | May 22, 2023

Anuh Pharma posts Q4 FY23 PAT at Rs. 9.62 Cr

Anuh Pharma has reported total income of Rs. 158.34 crores during the period ended March 31, 2023

Indian API companies to grow by 7-8% and operating profit margin to improve to 12-14% in FY2025: ICRA
Opinion | August 14, 2024

Indian API companies to grow by 7-8% and operating profit margin to improve to 12-14% in FY2025: ICRA

Capital expenditure expected to moderate to Rs. 5.6 billion in FY2025 from an estimated Rs. 7.6 billion in FY2024

Latest Stories

Eight Roads Ventures to host fourth edition of Scale-Up Health conference on Sept 10

Indoco Remedies receives final USFDA approval for rivaroxaban tablets

Senores Pharmaceuticals acquires ANDAs from Teva Pharmaceuticals USA

White Papers

Chasing Consistency: Centralizing operations data is the key to optimizing chemicals plants

Implementing a digital transformation in chemical operations to maximize profitability

The complexity of compliance

The Sprint to the Summit: Unlocking Lab Efficiency through Digital Transformation

The guiding role of fluidized and spouted bed technologies in particle building processes

Interviews
India remains a very important part of our ecosystem: Vaios Barlas, Global Director Healthcare, Clariant and Bhushan Thekedar, Head of Global Business Development Healthcare, Clariant
India remains a very important part of our ecosystem: Vaios Barlas, Global Director Healthcare, Clariant and Bhushan Thekedar, Head of Global Business Development Healthcare, Clariant
Capex commitment likely to be in the range of Rs. 200-300 Cr: Dr. R. Ananthanarayanan, CEO, Sajjan India
Capex commitment likely to be in the range of Rs. 200-300 Cr: Dr. R. Ananthanarayanan, CEO, Sajjan India
Dr. R. Ananthanarayanan CEO, Sajjan India
Our focus is on organic expansion and building our own plants...: Dr. Aman Desai, Promoter and Whole Time Director, Aether Industries
Our focus is on organic expansion and building our own plants...: Dr. Aman Desai, Promoter and Whole Time Director, Aether Industries
Dr. Aman Desai Promoter and Whole Time Director, Aether Industries

Packaging